Adaptimmune Therapeutics Plc - ADR

NASDAQ:ADAP   3:59:51 PM EDT
2.39
+0.14 (+6.22%)
Other Pre-Announcement

Adaptimmune Therapeutics Reports Quarterly Loss Per Share Of $0.05

Published: 08/04/2022 12:01 GMT
Adaptimmune Therapeutics Plc - ADR (ADAP) - Adaptimmune Therapeutics Plc - Qtrly Loss per Share $0.05; Qtrly Revenues $5.5 Million.
Adaptimmune Therapeutics Plc Says Reaffirming Financial Guidance.
Further Company Coverage: Adapo ((reuters.
Briefs@thomsonreuters.
Com;)).